phosphate buffered saline., FX06
TMP-2204-2021-47
Phase 2 small_molecule active
Quick answer
phosphate buffered saline., FX06 for Acute Respiratory Distress Syndrome (ARDS) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Acute Respiratory Distress Syndrome (ARDS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active